540596 Stock Overview
Eris Lifesciences Limited, together with its subsidiaries, engages in the manufacture, marketing, and distribution of domestic branded formulations for chronic and sub-chronic therapies in India.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 1/6 |
Eris Lifesciences Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹881.95 |
| 52 Week High | ₹971.00 |
| 52 Week Low | ₹605.20 |
| Beta | 0.41 |
| 1 Month Change | 4.74% |
| 3 Month Change | -0.11% |
| 1 Year Change | 39.81% |
| 3 Year Change | 46.70% |
| 5 Year Change | 39.80% |
| Change since IPO | 46.73% |
Recent News & Updates
Recent updates
Shareholder Returns
| 540596 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 1.3% | 1.4% | 2.8% |
| 1Y | 39.8% | 57.2% | 46.6% |
Return vs Industry: 540596 underperformed the Indian Pharmaceuticals industry which returned 55.9% over the past year.
Return vs Market: 540596 underperformed the Indian Market which returned 46.4% over the past year.
Price Volatility
| 540596 volatility | |
|---|---|
| 540596 Average Weekly Movement | 4.1% |
| Pharmaceuticals Industry Average Movement | 5.9% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 540596 has not had significant price volatility in the past 3 months.
Volatility Over Time: 540596's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | 3,548 | Amit Bakshi | www.eris.co.in |
Eris Lifesciences Limited, together with its subsidiaries, engages in the manufacture, marketing, and distribution of domestic branded formulations for chronic and sub-chronic therapies in India. The company offers various branded formulations in various therapeutic areas, such as anti–diabetes, anti-infective, blood related, cardiovascular, dermatology, gastrointestinal, gastroenterology, haematinics, hormones, nero/ central nervous system, neuropsychiatry, otologicals, pain/analgesics, respiratory, stomatologicals, cosmetology, women’s health, and vitamins/minerals/nutrients. It also provides patient care services, including blood pressure measurement, ambulatory electrocardiogram measurement, continuous glucose monitoring system, sleep study, and ante-natal care solutions.
Eris Lifesciences Limited Fundamentals Summary
| 540596 fundamental statistics | |
|---|---|
| Market cap | ₹120.21b |
| Earnings (TTM) | ₹3.86b |
| Revenue (TTM) | ₹18.41b |
31.1x
P/E Ratio6.5x
P/S RatioIs 540596 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 540596 income statement (TTM) | |
|---|---|
| Revenue | ₹18.41b |
| Cost of Revenue | ₹3.44b |
| Gross Profit | ₹14.97b |
| Other Expenses | ₹11.11b |
| Earnings | ₹3.86b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 28.40 |
| Gross Margin | 81.33% |
| Net Profit Margin | 21.00% |
| Debt/Equity Ratio | 34.2% |
How did 540596 perform over the long term?
See historical performance and comparison